other material
confidence high
sentiment negative
materiality 0.70
Baudax Bio, Inc.: auditor change — Baudax Bio dismisses EisnerAmper as auditor, engages KPMG; cites material weakness
Baudax Bio, Inc.
- Dismissed EisnerAmper on Oct 19, 2023; KPMG appointed as new independent auditor for FY 2023.
- EisnerAmper's 2022 report included a going-concern paragraph citing $190.9M accumulated deficit.
- Material weakness identified in Q2 2023 related to purchase price accounting for TeraImmune acquisition; no restatement.
- No disagreements between Company and EisnerAmper; KPMG previously served as auditor from 2019 to June 2022.
- Audit committee recommended change after competitive review; EisnerAmper letter filed as Exhibit 16.1.